IDO1 and neoplasm: Nonetheless, constitutive IDO1 expression in tumor cells is still a key factor to mediate immune evasion, and thus exploring the mechanism of up-expression may guide and pre-evaluate the efficacy of therapeutic approaches by targeting IDO1.